[1] Balamuth NJ, Womer RB. Ewing's sarcoma. Lancet Oncol. 2010 Feb;11(2):184-92. doi: 10.1016/S1470-2045(09)70286-4. PMID: 20152770.
[2] Eggli KD, Quiogue T, Moser RP Jr. Ewing's sarcoma. Radiol Clin North Am. 1993 Mar;31(2):325-37. PMID: 8446752.
[3] Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2009;152:3-13. doi: 10.1007/978-1-4419-0284-9_1. PMID: 20213383.
[4] Karosas AO. Ewing's sarcoma. Am J Health Syst Pharm. 2010 Oct 1;67(19):1599-605. doi: 10.2146/ajhp090526. PMID: 20852160.
[5] Vander Heiden MG, DeBerardinis RJ. Understanding the Intersections between Metabolism and Cancer Biology. Cell. 2017 Feb 9;168(4):657-669. doi: 10.1016/j.cell.2016.12.039. PMID: 28187287; PMCID: PMC5329766.
[6] DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Sci Adv. 2016 May 27;2(5): e1600200. doi: 10.1126/sciadv.1600200. PMID: 27386546; PMCID: PMC4928883.
[7] Li Z, Zhang H. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci. 2016 Jan;73(2):377-92. doi: 10.1007/s00018-015-2070-4. Epub 2015 Oct 23. PMID: 26499846.
[8] Dong Y, Yi X, Yujie Z, Huixia Z, Yan C. Relationship between the Methylation of Folic Acid Metabolism-Related Genes and the Incidence and Prognosis of Esophageal Cancer among Ethnic Kazakhs. J Cancer. 2018 Jul 30;9(16):2865-2875. doi: 10.7150/jca.25270. PMID: 30123355; PMCID: PMC6096358.
[9] Wen F, Huang J, Lu X, Huang W, Wang Y, Bai Y, Ruan S, Gu S, Chen X, Shu P. Identification and prognostic value of metabolism-related genes in gastric cancer. Aging (Albany NY). 2020 Sep 11;12(17):17647-17661. doi: 10.18632/aging.103838. Epub ahead of print. PMID: 32920549; PMCID: PMC7521523.
[10] Kondo T. Current Status of Proteomics in Ewing's Sarcoma. Proteomics Clin Appl. 2019 May;13(3): e1700130. doi: 10.1002/prca.201700130. Epub 2018 Aug 23. PMID: 29992772.
[11] Anderson JL, Titz B, Akiyama R, Komisopoulou E, Park A, Tap WD, Graeber TG, Denny CT. Phosphoproteomic profiling reveals IL6-mediated paracrine signaling within the Ewing sarcoma family of tumors. Mol Cancer Res. 2014 Dec;12(12):1740-54. doi: 10.1158/1541-7786.MCR-14-0159. Epub 2014 Aug 4. PMID: 25092916.
[12] Savola S, Klami A, Myllykangas S, Manara C et al. High Expression of Complement Component 5 (C5) at Tumor Site Associates with Superior Survival in Ewing's Sarcoma Family of Tumour Patients. ISRN Oncol 2011; 2011:168712. PMID: 22084725
[13] Li Z, Yu X, Shen J, Wu WK, Chan MT. MicroRNA expression and its clinical implications in Ewing's sarcoma. Cell Prolif. 2015 Feb;48(1):1-6. doi: 10.1111/cpr.12160. Epub 2014 Dec 22. PMID: 25530497; PMCID: PMC6496123.
[14] Astekar M, Saxena S, Murari A, Manjunatha BS. Ewing's sarcoma in maxilla. BMJ Case Rep. 2019 Feb 21;12(2): e227819. doi: 10.1136/bcr-2018-227819. PMID: 30796079; PMCID: PMC6388892.
[15] Moore DD, Haydon RC. Ewing's sarcoma of bone. Cancer Treat Res. 2014; 162:93-115. doi: 10.1007/978-3-319-07323-1_5. PMID: 25070232.
[16] Deng Y, Xie Q, Zhang G, Li S, Wu Z, Ma Z, He X, Gao Y, Wang Y, Kang X, Wang J. Slow skeletal muscle troponin T, titin and myosin light chain 3 are candidate prognostic biomarkers for Ewing's sarcoma. Oncol Lett. 2019 Dec;18(6):6431-6442. doi: 10.3892/ol.2019.11044. Epub 2019 Nov 4. PMID: 31807166; PMCID: PMC6876326.
[17] Mullen AR, Wheaton WW, Jin ES, Chen PH, Sullivan LB, Cheng T, Yang Y, Linehan WM, Chandel NS, DeBerardinis RJ. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature. 2011 Nov 20;481(7381):385-8. doi: 10.1038/nature10642. PMID: 22101431; PMCID: PMC3262117.
[18] Reuter D, Staege MS, Kühnöl CD, Föll J. Immunostimulation by OX40 Ligand Transgenic Ewing Sarcoma Cells. Front Oncol. 2015 Oct 27; 5: 242. doi: 10.3389/fonc.2015.00242. PMID: 26579494; PMCID: PMC4621427.
[19] Koppenhafer SL, Goss KL, Terry WW, Gordon DJ. Inhibition of the ATR-CHK1 Pathway in Ewing Sarcoma Cells Causes DNA Damage and Apoptosis via the CDK2-Mediated Degradation of RRM2. Mol Cancer Res. 2020 Jan;18(1):91-104. doi: 10.1158/1541-7786.MCR-19-0585. Epub 2019 Oct 24. PMID: 31649026; PMCID: PMC6942212.
[20] Goss KL, Koppenhafer SL, Waters T, Terry WW, Wen KK, Wu M, Ostergaard J, Gordon PM, Gordon DJ. The translational repressor 4E-BP1 regulates RRM2 levels and functions as a tumor suppressor in Ewing sarcoma tumors. Oncogene. 2021 Jan;40(3):564-577. doi: 10.1038/s41388-020-01552-0. Epub 2020 Nov 15. PMID: 33191406; PMCID: PMC7856031.
[21] Sottnik JL, Mallaredy V, Chauca-Diaz A, Ritterson Lew C, Owens C, Dancik GM, Pagliarani S, Lucchiari S, Moggio M, Ripolone M, Comi GP, Frierson HF, Clouthier D, Theodorescu D. Elucidating the role of Agl in bladder carcinogenesis by generation and characterization of genetically engineered mice. Carcinogenesis. 2019 Mar 12;40(1):194-201. doi: 10.1093/carcin/bgy139. PMID: 30403777; PMCID: PMC6753590.
[22] Wang H, Tong L, Wei J, Pan W, Li L, Ge Y, Zhou L, Yuan Q, Zhou C, Yang M. The ALDH7A1 genetic polymorphisms contribute to development of esophageal squamous cell carcinoma. Tumour Biol. 2014 Dec;35(12):12665-70. doi: 10.1007/s13277-014-2590-9. Epub 2014 Sep 12. PMID: 25213698.
[23] Zha T, Wu H. Expression of serum AMPD1 in thyroid carcinoma and its clinical significance. Exp Ther Med. 2018 Apr;15(4):3357-3361. doi: 10.3892/etm.2018.5859. Epub 2018 Feb 12. PMID: 29545855; PMCID: PMC5840934.
[24] Kawaguchi M, Han X, Hisada T, Nishikawa S, Kano K, Ieda N, Aoki J, Toyama T, Nakagawa H. Development of an ENPP1 Fluorescence Probe for Inhibitor Screening, Cellular Imaging, and Prognostic Assessment of Malignant Breast Cancer. J Med Chem. 2019 Oct 24;62(20):9254-9269. doi: 10.1021/acs.jmedchem.9b01213. Epub 2019 Oct 3. PMID: 31536342.
[25] Ide T, Brown-Endres L, Chu K, Ongusaha PP, Ohtsuka T, El-Deiry WS, Aaronson SA, Lee SW. GAMT, a p53-inducible modulator of apoptosis, is critical for the adaptive response to nutrient stress. Mol Cell. 2009 Nov 13;36(3):379-92. doi: 10.1016/j.molcel.2009.09.031. Retraction in: Mol Cell. 2013 Aug 22;51(4):552. PMID: 19917247; PMCID: PMC2779531.
[26] Liu F, Wu Y, Liu J, Ni RJ, Yang AG, Bian K, Zhang R. A miR-205-LPCAT1 axis contributes to proliferation and progression in multiple cancers. Biochem Biophys Res Commun. 2020 Jun 25;527(2):474-480. doi: 10.1016/j.bbrc.2020.04.071. Epub 2020 Apr 23. PMID: 32334831.